Intranasal Drug Halts Memory Decay in Experimental Alzheimer’s Model March 21, 2022 Intranasal delivery of biologically active lipid messengers halts memory loss and neurodegeneration in mouse models of Alzheimer's disease. from Neuroscience News https://ift.tt/9PLwBDi Share Get link Facebook X Pinterest Email Other Apps Labels Neuroscience News NSNews Share Get link Facebook X Pinterest Email Other Apps Comments
Intranasal delivery of biologically active lipid messengers halts memory loss and neurodegeneration in mouse models of Alzheimer's disease.
Comments
Post a Comment